Interprofessional Issues Novel, Interprofessional Approach Enhances Bed Assignments for Individuals on Antineoplastic Drugs in a Hospital Setting August 22, 2024
Nurse Empowerment Sharing Our Stories Supports, Celebrates, and Advances the Nursing Profession July 04, 2024
Trending Topics Research Safety Nurse Well-Being Drug Reference Sheets ONS Congress Specific Populations View All Topics
Cancer Research Acknowledge and End Unequal Representation in Cancer Research and Improve Access to Care August 11, 2020
U.S. Food and Drug Administration (FDA) FDA Approves First Liquid Biopsy NGS Companion Diagnostic Test for NSCLC August 11, 2020
U.S. Food and Drug Administration (FDA) FDA Grants Accelerated Approval to Belantamab Mafodotin-Blmf for Multiple Myeloma August 06, 2020
Treatment Side Effects Glioblastoma Diagnosis, Treatment, Side Effect Management, and Survivorship Recommendations August 06, 2020
U.S. Food and Drug Administration (FDA) FDA Grants Accelerated Approval to Tafasitamab-Cxix for Diffuse Large B-Cell Lymphoma August 04, 2020
U.S. Food and Drug Administration (FDA) FDA Approves Atezolizumab for BRAF V600 Unresectable or Metastatic Melanoma August 03, 2020
U.S. Food and Drug Administration (FDA) Oncology Drug Reference Sheet: Enfortumab Vedotin-Ejfv July 28, 2020
U.S. Food and Drug Administration (FDA) FDA Approves Brexucabtagene Autoleucel for Relapsed or Refractory MCL July 27, 2020
Survivorship Opioid-Related Death Rates Are Increasing, But Less So in Cancer Survivors July 16, 2020
Press Releases ONS Offers Companies the Oncology Nursing Society Seal of Approval™ to promote Oncology Nurse and Patient Support Materials July 13, 2020
Survivorship Myeloproliferative Neoplasm Symptoms, Diagnosis, Treatment, and Survivorship Recommendations July 09, 2020
U.S. Food and Drug Administration (FDA) FDA Approves Oral Combination of Decitabine and Cedazuridine for Myelodysplastic Syndromes July 08, 2020
Cancer Research Prostate Cancer Clinical Trials Don’t Reflect Racial Diversity—And It’s Getting Worse Over Time July 08, 2020
Cancer Healthcare Advocacy All Politics Is Local, and That’s Why You Should Get Involved in ONS Advocacy July 06, 2020
Oncology Drug Research FDA Approves Avelumab for Urothelial Carcinoma Maintenance Treatment July 02, 2020
Cancer Research Antibody-Drug Conjugates Join the Best of Two Worlds Into One New Treatment July 01, 2020
U.S. Food and Drug Administration (FDA) FDA Approves Pembrolizumab for First-Line Treatment of MSI-H/dMMR Colorectal Cancer June 30, 2020
Oncology Drug Research FDA Approves Combination of Pertuzumab, Trastuzumab, and Hyaluronidase-Zzxf for HER2-Positive Breast Cancer June 30, 2020
Oncology Drug Research FDA Approves Pembrolizumab for Treatment of Cutaneous Squamous Cell Carcinoma June 25, 2020
COVID-19 Cancer Consortium Report Reveals High Mortality Rates in Patients With COVID-19 and Cancer June 25, 2020
Oncology Drug Research FDA Approves Selinexor for Relapsed or Refractory Diffuse Large B-Cell Lymphoma June 23, 2020
U.S. Food and Drug Administration (FDA) HIV-Positive Patients With Cancer Need to Be Included in Clinical Drug Trials June 23, 2020
U.S. Food and Drug Administration (FDA) FDA Grants Accelerated Approval to Tazemetostat for Follicular Lymphoma June 19, 2020